The Latest in CLL

5-year data show deepening response with ibrutinib in CLL

May 11, 2018

CLL

Venetoclax shows muscle against CLL relapsed after idelalisib

April 18, 2018

CLL

Updated CLL guidelines incorporate a decade of advances

April 6, 2018

CLL

Experimental voxtalisib shows mixed results in phase 2 study

March 22, 2018

A global snapshot of leukemia incidence

March 13, 2018

CLL

Ibrutinib linked to invasive fungal infections

March 7, 2018

Baseline stress signals need for psychological help in CLL

February 23, 2018

CLL

CLL Index proves accurate in predicting survival, time to treat

February 5, 2018

CLL

VIDEO: Practice changers out of ASH 2017

January 25, 2018

CLL

CLL drug in limited supply outside U.S.

January 25, 2018

CLL

Venetoclax/rituximab boosts PFS in relapsed/refractory CLL

December 27, 2017

CLL

VIDEO: Venetoclax/rituximab prolongs PFS in relapsed/refractory CLL

December 12, 2017

CLL

CLL drug combinations induce MRD negativity

December 11, 2017

CLL

CLARITY: Ibrutinib/venetoclax combo results look promising for relapsed/refractory CLL

December 10, 2017

CLL

Late-breaking abstracts highlight treatment advances in CLL, myeloma, and more

November 22, 2017

CLL